Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Intergroup collaboration in ovarian cancer: the Gynecologic Cancer Intergroup (GCIG)
Autore:
Vermorken, JB;
Indirizzi:
Univ Antwerp Hosp, Dept Med Oncol, B-2650 Edegem, Belgium Univ Antwerp Hosp Edegem Belgium B-2650 ed Oncol, B-2650 Edegem, Belgium
Titolo Testata:
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
, volume: 11, anno: 2001, supplemento:, 1
pagine: 73 - 76
SICI:
1048-891X(2001)11:<73:ICIOCT>2.0.ZU;2-M
Fonte:
ISI
Lingua:
ENG
Soggetto:
STAGE-III; PACLITAXEL; CISPLATIN; TRIAL; CYCLOPHOSPHAMIDE;
Keywords:
Gynecologic Cancer Intergroup; intergroup collaboration; ovarian cancer;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Citazioni:
13
Recensione:
Indirizzi per estratti:
Indirizzo: Vermorken, JB Univ Antwerp Hosp, Dept Med Oncol, Wilrijkstr 10, B-2650 Edegem, Belgium Univ Antwerp Hosp Wilrijkstr 10 Edegem Belgium B-2650 lgium
Citazione:
J.B. Vermorken, "Intergroup collaboration in ovarian cancer: the Gynecologic Cancer Intergroup (GCIG)", INT J GYN C, 11, 2001, pp. 73-76

Abstract

Randomized clinical trials are considered the definitive source of evidence for guiding decisions in clinical practise. In patients with ovarian cancer many of the randomized trials from the 1970s and 1980s did not have the statistical power to detect realistic and clinically important differences. Therefore, evolution of so-called "optimal therapy" has been rather slow and some important questions have gone unanswered. In order to overcome thischallenge, representatives of different Cooperative Groups started an Ovarian Cancer Trials Intergroup Network in the mid 1990s, as a vehicle to develop future trial collaboration and as a mechanism for communication about strategic directions of phase I/II trials within individual Groups. In 1997 this network became more formalized, going beyond ovarian cancer as a single focus, and the Gynecologic Cancer Intergroup (GCIG) was created. At present GCIG includes representatives of 12 Cooperative Groups and the NCI-US, and functions as a forum for development of global trial collaborations, which hopefully will answer important questions in a more timely fashion and make them more rapidly available for the oncologic community.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 11/08/20 alle ore 14:56:49